Option chain shows key data for 's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for .

 (OTC:ISMJF) Stock, Option Chain

Precision Optics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>) reported quarterly losses of $(0.21) per share. This is a 162.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported $4.20 million in sales this quarter. This is a 2.88 percent decrease over sales of $4.32 million the same period last year.

Earnings

News

POCI

Precision Optics Corp Q1 EPS $(0.21) Down From $(0.08) YoY, Sales $4.20M Down From $4.32M YoY

Contracts

AXON

Axon To Supply Royal Canadian Mounted Police (RCMP) With Body-Worn Cameras

Ryvyl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.27) by 181.48 percent. This is a 26.67 percent decrease over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $12.61 million which missed the analyst consensus estimate of $13.92 million by 9.44 percent. This is a 27.88 percent decrease over sales of $17.48 million the same period last year.

Earnings Misses

RVYL

Ryvyl Q3 EPS $(0.76) Misses $(0.27) Estimate, Sales $12.61M Miss $13.92M Estimate

Hyliion Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYLN#NYSE">HYLN</a>) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent.

Earnings Beats

HYLN

Hyliion Holdings Q3 2024 GAAP EPS $(0.06) Beats $(0.07) Estimate

Super League Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.31) by 19.35 percent. This is a 78.45 percent increase over losses of $(1.16) per share from the same period last year. The company reported quarterly sales of $4.43 million which missed the analyst consensus estimate of $6.81 million by 34.91 percent. This is a 38.42 percent decrease over sales of $7.20 million the same period last year.

Super League Enterprise Q3 2024 Adj EPS $(0.25) Beats $(0.31) Estimate, Sales $4.43M Miss $6.81M Estimate

Biotech

Events

General

AMGN

Amgen To Present MITIGATE Phase 3 Study At ACR 2024 Nov. 14-19

Trading Ideas

WYNN

Appaloosa LP 13F Shows Added Stake In Vistra Corp With 1,270,388 Shares; Added Stake In NRG Energy With 999,820 Shares; Added Stake In Las Vegas Sands Corp With 1,528,323 Shares; Added Stake In Wynn Resorts Ltd With 800,000 Shares

Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) reported quarterly losses of $(0.93) per share. This is a 81.4 percent increase over losses of $(5.00) per share from the same period last year. The company reported $1.87 million in sales this quarter. This is a 89.65 percent increase over sales of $985.52 thousand the same period last year.

SIDU

Sidus Space Q3 EPS $(0.93) Up From $(5.00) YoY, Sales $1.87M Up From $985.52K YoY

Emeren Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) sees Q4 sales of $40.000 million-45.000 million vs $80.26 million estimate.

Guidance

Emeren Group Sees Q4 Sales $40.000M-45.000M vs $80.26M Est

Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) reported quarterly losses of $(0.23) per share. This is a 84.46 percent increase over losses of $(1.48) per share from the same period last year. The company reported $126.00 thousand in sales this quarter. This is a 55.32 percent decrease over sales of $282.00 thousand the same period last year.

TIVC

Tivic Health Systems Q3 EPS $(0.23) Up From $(1.48) YoY, Sales $126.00K Down From $282.00K YoY

WIIM

DMRC

Digimarc shares are trading lower after the company reported worse-than-expected Q3 financial results.

Genelux (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLX#NASDAQ">GNLX</a>) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent.

GNLX

Genelux Q3 2024 GAAP EPS $(0.19) Beats $(0.20) Estimate

2024 Fourth Quarter and Full Year Outlook
Based on current market conditions, Globant is providing the following estimates for the fourth quarter and the full year of 2024:
<ul>
<li>Fourth quarter 2024 Revenues are estimated to be in the range of $642.0 million to $648.0 million, or 10.6% to 11.6% year-over-year growth.</li>
<li>Fourth quarter 2024 Non-IFRS Adjusted Profit from Operations Margin is estimated to be in the range of 15.0% to 16.0%.</li>
<li>Fourth quarter 2024 Non-IFRS Adjusted Diluted EPS is estimated to be in the range of $1.71 to $1.75 (assuming an average of 44.7 million diluted shares outstanding during the fourth quarter).</li>
<li>Fiscal year 2024 Revenues are estimated to be in the range of $2,415.0 million to $2,421.0 million, implying a 15.2% to 15.5% year-over-year revenue growth.</li>
<li>Fiscal year 2024 Non-IFRS Adjusted Profit from Operations Margin is estimated to be in the range of 15.0% to 15.5%.</li>
<li>Fiscal year 2024 Non-IFRS Adjusted Diluted EPS is estimated to be in the range of $6.37 to $6.43 (assuming an average of 44.5 million diluted shares outstanding during 2024).</li>
</ul>

GLOB

Globant S.A. Sees Q4 Adj. EPS $1.71-$1.75 Vs $1.74 Est.; Revenue $642M-$648M Vs $643M Est.; FY24 EPS $6.37-$6.43 Vs $6.40 Est.; Revenue $2.415B-$2.421B Vs $2.42B Est.

Panbela Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBLA#NASDAQ">PBLA</a>) reported quarterly losses of $(1.48) per share. This is a 97.25 percent increase over losses of $(53.74) per share from the same period last year.

PBLA

Panbela Therapeutics Q3 EPS $(1.48) Up From $(53.74) YoY

SWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKH#NASDAQ">SWKH</a>) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.52 by 36.54 percent. The company reported $10.418 million in sales this quarter. This is a 16.25 percent increase over sales of $8.962 million the same period last year.

SWKH

SWK Holdings Q3 2024 Adj. EPS $0.33 Misses $0.52 Estimate, Sales $10.418M Up From $8.962M YoY

GameSquare Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAME#NASDAQ">GAME</a>) sees FY2024 sales of $105.000 million-$110.000 million vs $103.00 million estimate.

GAME

GameSquare Holdings Sees FY2024 Sales $105.000M-$110.000M vs $103.00M Est

POLA

Polar Power Q3 EPS $0.00 Up From $(0.14) YoY; Revenue $4.914M Up From $1.911M YoY

Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) reported quarterly earnings of $1.63 per share which met the analyst consensus estimate. This is a 10.14 percent increase over earnings of $1.48 per share from the same period last year. The company reported quarterly sales of $614.67 million which missed the analyst consensus estimate of $614.82 million by 0.02 percent. This is a 12.72 percent increase over sales of $545.28 million the same period last year.

Globant Q3 Adj $1.63, Inline, Sales $614.67M Miss $614.82M Estimate

Esco Technologies Sees FY25 Net Sales $1.09B-$1.11B, Adj. EPS $4.70-$4.90l Sees Q1 2025 Adj. EPS $0.68-$0.75

Unusual Machines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#AMEX">UMAC</a>) reported quarterly losses of $(0.30) per share. This is a 172.73 percent decrease over losses of $(0.11) per share from the same period last year. The company reported $1.53 million in sales this quarter.

UMAC

Unusual Machines Q3 EPS $(0.30) Down From $(0.11) YoY, Sales $1.53M

BlackRock iShares Core MSCI Pacific ex Japan UCITS ETF USD (Acc)

Comments

(ISMJF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga